title: Fenfluramine: riddle or Rosetta stone?
authors.forename: E K
authors.initials: EK
authors.lastname: Weir
authors.forename: M
authors.initials: M
authors.lastname: Obreztchikova
authors.forename: Z
authors.initials: Z
authors.lastname: Hong
mesh_terms: D000818:Animals; D001067:Appetite Depressants / Q000009:adverse effects* / Q000627:therapeutic use; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D005277:Fenfluramine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced* / Q000453:epidemiology; D015994:Incidence; D011664:Pulmonary Valve / Q000187:drug effects / Q000503:physiopathology; D051381:Rats; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012701:Serotonin / Q000378:metabolism; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D001067:Appetite Depressants; D005277:Fenfluramine; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors